Example using IPIX B-OM phase2 percentages. Let’s use

New Post Public Reply Private Reply Replies (1) Message Board
Mo
323
Example using IPIX B-OM phase2 percentages. Let’s use the low and more conservative 60% for placebo vs the more realistic 75% number seen in previous trials. So if there were 1000 patients being treated with Throat and Neck cancer at least 600 would get OM without any treatment to PREVENT getting OM. If those same 1000 patients did a simple swish and spit 3 times a day with B there would be 368 people that still would get OM meaning 232 of the 600 would NOT GET the OM disease by using B. (Per protocol population of 36.8% so 368 people vs 600 people). Reducing the odds of getting OM by 38.66% (232/600). So using the conservative 60 placebo number B will reduce the chances of GETTING OM by 38.66%. Using a more realistic number of 75% instance of getting OM that number goes from 38.66% to 50.93% PREVENTION rate. If you could reduce your chances of getting a disease that makes it extremely difficult to eat, drink or swallow by 39-51% by doing a simple swish and spit would you do it? If you were a doctor that cared for your patient’s well-being would you subscribe it? BTW, there were ZERO instances of SAE related to B (extremely safe to use). As others have mentioned we haven’t even seen secondary data to see improvements of symptoms using B which is gravy on top of meeting the study’s primary endpoint. I am a retired computer sales guy with zero medical background. Do you think the medical and business people in big pharma with full access to all the data under NDA will figure this out? My money says they will/have.

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

HONA Faces Legal Heat: Investor Lawsuit Over Losses

Updated Category News Views 5

The Investor Storm Brewing Over Honeywell Aerospace There it is again, another industry heavyweight caught in a dizzying whirlwind of litigation. Honeywell Aerospace Inc. (NASDAQ:HONA), a name as established as an old boot in the business, now faces a class action lawsuit that's got investors frantically dusting off phone numbers for their attorneys. The Messy Allegations...

Continue Reading
Krispy Kreme Faces Legal Probe: Fiduciary Breach?

Updated Category News Views 3

Diving Deep into the Krispy Kreme Allegations Look, this isn't your run-of-the-mill donut drama. When you hear rumblings of corporate missteps, especially ones that involve potential breaches of fiduciary duties, it's time to perk up those ears. Over at Krispy Kreme, Inc. (NASDAQ:DNUT), there's some heat in the kitchen, and it's not just from frying those glazed beauties....

Continue Reading
CVS Health Under Fire: Fiduciary Duty Breach?

Updated Category News Views 2

CVS Under Regulatory Spotlight for Fiduciary Breaches You'd think by now companies would have their fiduciary ducks in a row. But here we are, with CVS Health Corporation (NYSE: CVS) catching heat from the legal eagles over at Halper Sadeh LLC. The knife’s out for some of the big wigs – apparently, there's chatter they might’ve slipped on their duty to play nice...

Continue Reading
Jackson Wang's Fantasy IP Hits Hong Kong Stage

Updated Category News Views 4

A Star-Studded Fantasy Comes Alive Hong Kong isn't just about dim sum and skyline views—it's a magnet for celebrity showcases, and this time, Jackson Wang's pulling the strings. The guy's ventured beyond music and idol fame, diving head-first into creative visuals with his fantasy IP, "Under the Castle" (UTC). Pairing up with Ocean Park's Halloween Fest, he's cooked up...

Continue Reading
Quay Sunglasses: Luxury Looks, Affordable Prices

Updated Category News Views 2

Ah, sunglasses—the quintessential accessory that screams both practicality and style. A million-dollar look without the million-dollar expense? That's where Quay comes in. They've been recognized by Expert Consumers, no less, as some of the best-in-class for affordable luxury eye candy out there—aimed at shoppers who want the designer vibe without the hemorrhaging...

Continue Reading
AI and Storytelling Make Waves in Science Education

Updated Category News Views 4

University's Innovative Approach to Learning Alright, here's something you don't see every day. The University of Phoenix managed to snag some kudos from an academic journal for using AI and storytelling to teach environmental science. That's like hitting two bulls-eyes with one shot in the world of education. The recognition from Glacies for this Editor's Choice paper...

Continue Reading
PACS Group Faces Legal Scrutiny: What to Watch

Updated Category News Views 3

PACS Group: Legal Storm Brewing Welcome to the latest saga in the volatile theater of corporate governance. PACS Group, Inc., ticker symbol NYSE:PACS, is under the microscope, and not for debuting a groundbreaking product or hitting a stock milestone. Nope, instead we've got Halper Sadeh LLC out of New York investigating some possible hanky-panky from PACS directors and...

Continue Reading
Geron Corp Faces Fiduciary Duty Investigation

Updated Category News Views 4

Spotlight on Geron's Corporate Governance: What's Happening? The heat's been turned up on Geron Corporation this week, with Halper Sadeh LLC, an investor rights law outfit, digging into whether some folks at the helm have strayed from their fiduciary duties to the shareholders. Now, if you're holding onto NASDAQ:GERN stock or thinking about diving in, it's high time to...

Continue Reading

Top 5 Most Recently Viewed Articles

Perella Weinberg Partners Prepares for Q3 2024 Financial Results

Updated Category News Views 155

Upcoming Financial Results Announcement from Perella Weinberg Perella Weinberg Partners (NASDAQ:PWP) has excitedly prepared to unveil its financial results for the third quarter of 2024, scheduled for a release on a significant Friday morning. This independent advisory firm has established itself as a leading player in the financial sector, and its upcoming reports are...

Continue Reading
Protalix BioTherapeutics Set for an Inspiring Virtual Conference

Updated Category News Views 251

Protalix BioTherapeutics to Showcase Innovations at Virtual Conference Protalix BioTherapeutics, Inc. (NYSE American: PLX), a leader in biopharmaceuticals focused on recombinant therapeutic proteins, is gearing up for participation in an upcoming virtual conference. This event, hosted by iAccess Alpha, promises to deliver valuable insights into the company's latest...

Continue Reading
Wingstop and American Red Cross Unite for Wildfire Relief

Updated Category News Views 298

Wingstop's Commitment to Community Support Wingstop Inc. has taken a commendable step to support communities struggling from the effects of devastating wildfires. By partnering with the American Red Cross, they are making it easier for patrons to play a crucial role in wildfire relief efforts. Through their Round-Up campaign, customers can round their order total up to...

Continue Reading
Harvia Plc Declares Exciting New Dividend for Shareholders

Updated Category News Views 192

Harvia Plc Declares New Dividend Announcement Harvia Plc has made an important announcement regarding dividends that will benefit its devoted shareholders. Recently, the company’s Board of Directors confirmed the details for the upcoming dividend payment, setting a record date and payment date that represents a commitment to returning value to its investors. Details of...

Continue Reading
Propy Launches Innovative Instant Onchain Loan for Real Estate

Updated Category News Views 245

Transforming the Real Estate Landscape with Blockchain A groundbreaking approach to purchasing properties has emerged, blending the benefits of cryptocurrency with real estate transactions. Propy is at the forefront of this transformation, bringing forth a novel financing option that allows buyers to leverage both cryptocurrency and their properties as collateral. This...

Continue Reading